Drug Resistance in Glioma Cells Induced by a Mesenchymal–Amoeboid Migratory Switch

Drug Resistance in Glioma Cells Induced by a Mesenchymal–Amoeboid Migratory Switch

Cancer cell invasion is a precondition for tumour metastasis and represents one of the most devastating characteristics of cancer. The development of drugs targeting cell migration, known as migrastatics, may improve the treatment of highly invasive tumours such as glioblastoma (GBM). In this study,...

Full description

Bibliographic Details
Main Authors: Sophie E. Ketchen, Filomena O. Gamboa-Esteves, Sean E. Lawler, Michal O. Nowicki, Arndt Rohwedder, Sabine Knipp, Sally Prior, Susan C. Short, John E. Ladbury, Anke Brüning-Richardson
Format: Article
Language:English
Published: MDPI AG 2021-12-01
Series:Biomedicines
Subjects:
migration
invasion
glioblastoma
CCN1
mesenchymal–amoeboid transition
biomarker
Online Access:https://www.mdpi.com/2227-9059/10/1/9

Internet

https://www.mdpi.com/2227-9059/10/1/9

Similar Items